APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Vaccines

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Selected research

Market Analysis & Forecast

Global DNA Vaccines Market Analysis and Forecast 2026-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchDNA Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Vaccines Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal DNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

This report presents an overview of global market for DNA Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of DNA Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for DNA Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for DNA Vaccines sales, projected growth trends, production technology, application and end-user industry.

DNA Vaccines Segment by Company

Merck

GSK

Sanofi

Zoties

Elanco

Boehringer-Ingelheim

Indian Immunologicals

Plumbline Life Sciences

DNA Vaccines Segment by Type

Recombinant Protein Vaccine

Gene-Based Vaccine

DNA Vaccines Segment by Application

Human

Animal

DNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of DNA Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Protein Vaccine Major Manufacturers Table 3. Gene-Based Vaccine Major Manufacturers Table 4. Global DNA Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Human Major Manufacturers Table 6. Animal Major Manufacturers Table 7. DNA Vaccines Industry Trends Table 8. DNA Vaccines Industry Drivers Table 9. DNA Vaccines Industry Opportunities and Challenges Table 10. DNA Vaccines Industry Restraints Table 11. Global DNA Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global DNA Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global DNA Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global DNA Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global DNA Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global DNA Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Doses) Table 17. Global DNA Vaccines Sales by Region (2021-2026) & (K Doses) Table 18. Global DNA Vaccines Sales by Region (2027-2032) & (K Doses) Table 19. Global DNA Vaccines Sales Market Share by Region (2021-2026) Table 20. Global DNA Vaccines Sales Market Share by Region (2027-2032) Table 21. Global DNA Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global DNA Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global DNA Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global DNA Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global DNA Vaccines Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 26. Global DNA Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global DNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global DNA Vaccines Manufacturers, Product Type & Application Table 29. Global DNA Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global DNA Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global DNA Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global DNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global DNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global DNA Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global DNA Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global DNA Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 38. Global DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 39. Global DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 40. Global DNA Vaccines Sales Market Share by Type (2021-2026) Table 41. Global DNA Vaccines Sales Market Share by Type (2027-2032) Table 42. Global DNA Vaccines Price by Type (2021-2026) & (US$/Dose) Table 43. Global DNA Vaccines Price by Type (2027-2032) & (US$/Dose) Table 44. Global DNA Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global DNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global DNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global DNA Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global DNA Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global DNA Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 50. Global DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 51. Global DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 52. Global DNA Vaccines Sales Market Share by Application (2021-2026) Table 53. Global DNA Vaccines Sales Market Share by Application (2027-2032) Table 54. Global DNA Vaccines Price by Application (2021-2026) & (US$/Dose) Table 55. Global DNA Vaccines Price by Application (2027-2032) & (US$/Dose) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 59. Merck DNA Vaccines Product Portfolio Table 60. Merck Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 64. GSK DNA Vaccines Product Portfolio Table 65. GSK Recent Development Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 69. Sanofi DNA Vaccines Product Portfolio Table 70. Sanofi Recent Development Table 71. Zoties Company Information Table 72. Zoties Business Overview Table 73. Zoties DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 74. Zoties DNA Vaccines Product Portfolio Table 75. Zoties Recent Development Table 76. Elanco Company Information Table 77. Elanco Business Overview Table 78. Elanco DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 79. Elanco DNA Vaccines Product Portfolio Table 80. Elanco Recent Development Table 81. Boehringer-Ingelheim Company Information Table 82. Boehringer-Ingelheim Business Overview Table 83. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 84. Boehringer-Ingelheim DNA Vaccines Product Portfolio Table 85. Boehringer-Ingelheim Recent Development Table 86. Indian Immunologicals Company Information Table 87. Indian Immunologicals Business Overview Table 88. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 89. Indian Immunologicals DNA Vaccines Product Portfolio Table 90. Indian Immunologicals Recent Development Table 91. Plumbline Life Sciences Company Information Table 92. Plumbline Life Sciences Business Overview Table 93. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 94. Plumbline Life Sciences DNA Vaccines Product Portfolio Table 95. Plumbline Life Sciences Recent Development Table 96. North America DNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 97. North America DNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 98. North America DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 99. North America DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 100. North America DNA Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 101. North America DNA Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 102. North America DNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 103. North America DNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 104. North America DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 105. North America DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 106. North America DNA Vaccines Sales Price by Application (2021-2026) & (US$/Dose) Table 107. North America DNA Vaccines Sales Price by Application (2027-2032) & (US$/Dose) Table 108. North America DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America DNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America DNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America DNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 112. North America DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 113. North America DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 114. North America DNA Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 115. North America DNA Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 116. United States DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 117. Canada DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 118. Mexico DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 119. Europe DNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe DNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 122. Europe DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 123. Europe DNA Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 124. Europe DNA Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 125. Europe DNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe DNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 128. Europe DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 129. Europe DNA Vaccines Sales Price by Application (2021-2026) & (US$/Dose) Table 130. Europe DNA Vaccines Sales Price by Application (2027-2032) & (US$/Dose) Table 131. Europe DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe DNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe DNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe DNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 135. Europe DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 136. Europe DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 137. Europe DNA Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 138. Europe DNA Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 139. Germany DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 140. France DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 141. U.K. DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 142. Italy DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 143. Russia DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 144. Spain DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 145. Netherlands DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 146. Switzerland DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 147. Sweden DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 148. Poland DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 149. China DNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 150. China DNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 151. China DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 152. China DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 153. China DNA Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 154. China DNA Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 155. China DNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 156. China DNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 157. China DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 158. China DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 159. China DNA Vaccines Sales Price by Application (2021-2026) & (US$/Dose) Table 160. China DNA Vaccines Sales Price by Application (2027-2032) & (US$/Dose) Table 161. Asia DNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia DNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 164. Asia DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 165. Asia DNA Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 166. Asia DNA Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 167. Asia DNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia DNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 170. Asia DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 171. Asia DNA Vaccines Sales Price by Application (2021-2026) & (US$/Dose) Table 172. Asia DNA Vaccines Sales Price by Application (2027-2032) & (US$/Dose) Table 173. Asia DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia DNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia DNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia DNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 177. Asia DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 178. Asia DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 179. Asia DNA Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 180. Asia DNA Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 181. Japan DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 182. South Korea DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 183. India DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Australia DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Taiwan DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 187. SAMEA DNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA DNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 190. SAMEA DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 191. SAMEA DNA Vaccines Sales Price by Type (2021-2026) & (US$/Dose) Table 192. SAMEA DNA Vaccines Sales Price by Type (2027-2032) & (US$/Dose) Table 193. SAMEA DNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA DNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 196. SAMEA DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 197. SAMEA DNA Vaccines Sales Price by Application (2021-2026) & (US$/Dose) Table 198. SAMEA DNA Vaccines Sales Price by Application (2027-2032) & (US$/Dose) Table 199. SAMEA DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA DNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA DNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA DNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Doses) Table 203. SAMEA DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 204. SAMEA DNA Vaccines Sales by Country (2027-2032) & (K Doses) Table 205. SAMEA DNA Vaccines Sales Price by Country (2021-2026) & (US$/Dose) Table 206. SAMEA DNA Vaccines Sales Price by Country (2027-2032) & (US$/Dose) Table 207. Brazil DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 208. Argentina DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Chile DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Colombia DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Peru DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Israel DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 214. UAE DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Turkey DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Iran DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Egypt DNA Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. DNA Vaccines Distributors List Table 221. DNA Vaccines Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. DNA Vaccines Image Figure 2. Global DNA Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Protein Vaccine Image Figure 5. Gene-Based Vaccine Image Figure 6. Global DNA Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global DNA Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Human Image Figure 9. Animal Image Figure 10. Global DNA Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global DNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global DNA Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global DNA Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global DNA Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global DNA Vaccines Sales (2021-2032) & (K Doses) Figure 16. Global DNA Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Figure 17. Global DNA Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico DNA Vaccines Sales YoY (2021-2032) & (K Doses) Figure 19. Europe DNA Vaccines Sales YoY (2021-2032) & (K Doses) Figure 20. China DNA Vaccines Sales YoY (2021-2032) & (K Doses) Figure 21. Asia (Excluding China) DNA Vaccines Sales YoY (2021-2032) & (K Doses) Figure 22. South America, Middle East and Africa DNA Vaccines Sales YoY (2021-2032) & (K Doses) Figure 23. Global DNA Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global DNA Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global DNA Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global DNA Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global DNA Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global DNA Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 30. Global DNA Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global DNA Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global DNA Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global DNA Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global DNA Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global DNA Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 36. Global DNA Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global DNA Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America DNA Vaccines Revenue Share by Type (2021-2032) Figure 39. North America DNA Vaccines Sales Share by Type (2021-2032) Figure 40. North America DNA Vaccines Revenue Share by Application (2021-2032) Figure 41. North America DNA Vaccines Sales Share by Application (2021-2032) Figure 42. North America DNA Vaccines Revenue Share by Country (2021-2032) Figure 43. North America DNA Vaccines Sales Share by Country (2021-2032) Figure 44. Europe DNA Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe DNA Vaccines Sales Share by Type (2021-2032) Figure 46. Europe DNA Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe DNA Vaccines Sales Share by Application (2021-2032) Figure 48. Europe DNA Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe DNA Vaccines Sales Share by Country (2021-2032) Figure 50. China DNA Vaccines Revenue Share by Type (2021-2032) Figure 51. China DNA Vaccines Sales Share by Type (2021-2032) Figure 52. China DNA Vaccines Revenue Share by Application (2021-2032) Figure 53. China DNA Vaccines Sales Share by Application (2021-2032) Figure 54. Asia DNA Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia DNA Vaccines Sales Share by Type (2021-2032) Figure 56. Asia DNA Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia DNA Vaccines Sales Share by Application (2021-2032) Figure 58. Asia DNA Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia DNA Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA DNA Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA DNA Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA DNA Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA DNA Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA DNA Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA DNA Vaccines Sales Share by Country (2021-2032) Figure 66. DNA Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. DNA Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Protein Vaccine
  • Gene-Based Vaccine
Applications
  • Human
  • Animal
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Zoties
  • Elanco
  • Boehringer-Ingelheim
  • Indian Immunologicals
  • Plumbline Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA Vaccines Market by Type
  3. 1.2.1 Global DNA Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Protein Vaccine
  5. 1.2.3 Gene-Based Vaccine
  6. 1.3 DNA Vaccines Market by Application
  7. 1.3.1 Global DNA Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Human
  9. 1.3.3 Animal
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 DNA Vaccines Market Dynamics
  1. 2.1 DNA Vaccines Industry Trends
  2. 2.2 DNA Vaccines Industry Drivers
  3. 2.3 DNA Vaccines Industry Opportunities and Challenges
  4. 2.4 DNA Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global DNA Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global DNA Vaccines Revenue by Region
  3. 3.2.1 Global DNA Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global DNA Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global DNA Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global DNA Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global DNA Vaccines Sales by Region
  9. 3.4.1 Global DNA Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global DNA Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global DNA Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global DNA Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global DNA Vaccines Revenue by Manufacturers
  2. 4.1.1 Global DNA Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global DNA Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global DNA Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA Vaccines Sales by Manufacturers
  6. 4.2.1 Global DNA Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global DNA Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global DNA Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global DNA Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global DNA Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global DNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global DNA Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global DNA Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global DNA Vaccines Market CR5 and HHI
  16. 4.8.2 2025 DNA Vaccines Tier 1, Tier 2, and Tier 3
5 DNA Vaccines Market by Type
  1. 5.1 Global DNA Vaccines Revenue by Type
  2. 5.1.1 Global DNA Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global DNA Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global DNA Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global DNA Vaccines Sales by Type
  6. 5.2.1 Global DNA Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DNA Vaccines Sales by Type (2021-2032) & (K Doses)
  8. 5.2.3 Global DNA Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global DNA Vaccines Price by Type
6 DNA Vaccines Market by Application
  1. 6.1 Global DNA Vaccines Revenue by Application
  2. 6.1.1 Global DNA Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global DNA Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global DNA Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global DNA Vaccines Sales by Application
  6. 6.2.1 Global DNA Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global DNA Vaccines Sales by Application (2021-2032) & (K Doses)
  8. 6.2.3 Global DNA Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global DNA Vaccines Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck DNA Vaccines Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK DNA Vaccines Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi DNA Vaccines Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Zoties
  20. 7.4.1 Zoties Company Information
  21. 7.4.2 Zoties Business Overview
  22. 7.4.3 Zoties DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zoties DNA Vaccines Product Portfolio
  24. 7.4.5 Zoties Recent Developments
  25. 7.5 Elanco
  26. 7.5.1 Elanco Company Information
  27. 7.5.2 Elanco Business Overview
  28. 7.5.3 Elanco DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Elanco DNA Vaccines Product Portfolio
  30. 7.5.5 Elanco Recent Developments
  31. 7.6 Boehringer-Ingelheim
  32. 7.6.1 Boehringer-Ingelheim Company Information
  33. 7.6.2 Boehringer-Ingelheim Business Overview
  34. 7.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
  36. 7.6.5 Boehringer-Ingelheim Recent Developments
  37. 7.7 Indian Immunologicals
  38. 7.7.1 Indian Immunologicals Company Information
  39. 7.7.2 Indian Immunologicals Business Overview
  40. 7.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Indian Immunologicals DNA Vaccines Product Portfolio
  42. 7.7.5 Indian Immunologicals Recent Developments
  43. 7.8 Plumbline Life Sciences
  44. 7.8.1 Plumbline Life Sciences Company Information
  45. 7.8.2 Plumbline Life Sciences Business Overview
  46. 7.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
  48. 7.8.5 Plumbline Life Sciences Recent Developments
8 North America
  1. 8.1 North America DNA Vaccines Market Size by Type
  2. 8.1.1 North America DNA Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America DNA Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America DNA Vaccines Price by Type (2021-2032)
  5. 8.2 North America DNA Vaccines Market Size by Application
  6. 8.2.1 North America DNA Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America DNA Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America DNA Vaccines Price by Application (2021-2032)
  9. 8.3 North America DNA Vaccines Market Size by Country
  10. 8.3.1 North America DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America DNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America DNA Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe DNA Vaccines Market Size by Type
  2. 9.1.1 Europe DNA Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe DNA Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe DNA Vaccines Price by Type (2021-2032)
  5. 9.2 Europe DNA Vaccines Market Size by Application
  6. 9.2.1 Europe DNA Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe DNA Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe DNA Vaccines Price by Application (2021-2032)
  9. 9.3 Europe DNA Vaccines Market Size by Country
  10. 9.3.1 Europe DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe DNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe DNA Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China DNA Vaccines Market Size by Type
  2. 10.1.1 China DNA Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China DNA Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China DNA Vaccines Price by Type (2021-2032)
  5. 10.2 China DNA Vaccines Market Size by Application
  6. 10.2.1 China DNA Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China DNA Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China DNA Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA Vaccines Market Size by Type
  2. 11.1.1 Asia DNA Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia DNA Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia DNA Vaccines Price by Type (2021-2032)
  5. 11.2 Asia DNA Vaccines Market Size by Application
  6. 11.2.1 Asia DNA Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia DNA Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia DNA Vaccines Price by Application (2021-2032)
  9. 11.3 Asia DNA Vaccines Market Size by Country
  10. 11.3.1 Asia DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia DNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia DNA Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA Vaccines Market Size by Type
  2. 12.1.1 SAMEA DNA Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA DNA Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA DNA Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA DNA Vaccines Market Size by Application
  6. 12.2.1 SAMEA DNA Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA DNA Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA DNA Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA DNA Vaccines Market Size by Country
  10. 12.3.1 SAMEA DNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA DNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA DNA Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 DNA Vaccines Value Chain Analysis
  2. 13.1.1 DNA Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 DNA Vaccines Production Mode & Process
  6. 13.2 DNA Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 DNA Vaccines Distributors
  9. 13.2.3 DNA Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst